Literature DB >> 28742638

Extraocular Muscle Findings in Myasthenia Gravis Associated Treatment-Resistant Ophthalmoplegia.

Robyn M Rautenbach1, Komala Pillay, Anthony D N Murray, Jeannine M Heckmann.   

Abstract

We report the histopathological and ultrastructural tissue analysis of extraocular muscle (EOM) obtained from a patient with seronegative myasthenia gravis (MG) with treatment-resistant ophthalmoplegia for 3.5 years. The EOM demonstrated predominantly myopathic features and ultrastructural evidence of mitochondrial dysfunction, but the most striking features were increased endomysial collagen and adipocyte replacement of muscle fibers. By contrast, control EOM from a patient undergoing strabismus surgery for a sensory exotropia in a nonseeing eye and a similar duration of deviation, showed normal muscle histology. Although the histopathological and ultrastructural findings largely resemble those of limb muscle in MG, the abundant endomysial collagen may be nonspecific and secondary to poor force generation as a result of chronic ophthalmoplegia.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28742638     DOI: 10.1097/WNO.0000000000000534

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  9 in total

1.  Mitochondrial bioenergetics in ocular fibroblasts of two myasthenia gravis cases.

Authors:  Tarin A Europa; Melissa Nel; Maribanyana R Lebeko; Jeannine M Heckmann
Journal:  IBRO Neurosci Rep       Date:  2022-04-21

2.  Ophthalmologic manifestations in myasthenia gravis: presentation and prognosis.

Authors:  Onur Akan; Leyla Baysal-Kirac
Journal:  Acta Neurol Belg       Date:  2021-01-04       Impact factor: 2.396

3.  Profiling of patient-specific myocytes identifies altered gene expression in the ophthalmoplegic subphenotype of myasthenia gravis.

Authors:  Melissa Nel; Sharon Prince; Jeannine M Heckmann
Journal:  Orphanet J Rare Dis       Date:  2019-01-29       Impact factor: 4.123

4.  Histopathologic study of extraocular muscles in thyroid-associated ophthalmopathy coexisting with ocular myasthenia gravis: a case report.

Authors:  Ruiqi Ma; Yun Cheng; Lu Gan; Xiaoting Zhou; Jiang Qian
Journal:  BMC Ophthalmol       Date:  2020-04-22       Impact factor: 2.209

5.  Gene expression profiling of orbital muscles in treatment-resistant ophthalmoplegic myasthenia gravis.

Authors:  Tarin A Europa; Melissa Nel; Jeannine M Heckmann
Journal:  Orphanet J Rare Dis       Date:  2020-12-11       Impact factor: 4.123

6.  Mitochondrial dynamics and biogenesis indicators may serve as potential biomarkers for diagnosis of myasthenia gravis.

Authors:  Lanqi Li; Donghong Cai; Huiya Zhong; Fengbin Liu; Qilong Jiang; Jian Liang; Peiwu Li; Yafang Song; Aidong Ji; Wei Jiao; Jingwei Song; Jinqiu Li; Zhiwei Chen; Qing Li; Lingling Ke
Journal:  Exp Ther Med       Date:  2022-02-24       Impact factor: 2.447

Review 7.  The Epidemiology and Phenotypes of Ocular Manifestations in Childhood and Juvenile Myasthenia Gravis: A Review.

Authors:  Jeannine M Heckmann; Tarin A Europa; Aayesha J Soni; Melissa Nel
Journal:  Front Neurol       Date:  2022-02-23       Impact factor: 4.003

8.  Total Plasma Exchange in Neuromuscular Junction Disorders-A Single-Center, Retrospective Analysis of the Efficacy, Safety and Potential Diagnostic Properties in Doubtful Diagnosis.

Authors:  Andreas Totzeck; Michael Jahn; Benjamin Stolte; Andreas Thimm; Christoph Kleinschnitz; Tim Hagenacker
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

9.  The feasibility of quantitative MRI of extra-ocular muscles in myasthenia gravis and Graves' orbitopathy.

Authors:  Kevin R Keene; Luc van Vught; Nienke M van de Velde; Isabeau A Ciggaar; Irene C Notting; Stijn W Genders; Jan J G M Verschuuren; Martijn R Tannemaat; Hermien E Kan; Jan-Willem M Beenakker
Journal:  NMR Biomed       Date:  2020-09-07       Impact factor: 4.044

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.